已收盘 02-06 16:00:00 美东时间
+0.830
+2.65%
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
UBS maintains Corporacion Inmobiliaria (NYSE:VTMX) with a Buy and raises the price target from $35 to $39.
2025-12-18 02:16
今日重点评级关注:Ascendiant Capital:维持Aclarion"买入"评级,目标价从22美元升至23美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从24美元升至26美元
2025-11-21 15:50
Barclays analyst Pablo Monsivais maintains Corporacion Inmobiliaria (NYSE:VTMX) with a Overweight and raises the price target from $38 to $40.
2025-11-21 03:42
Corporacion Inmobiliaria (NYSE:VTMX) sees Revenue for 2025 FY is expected to up by 10 to 11% YoY
2025-10-24 05:24
Vesta Real Estate (NYSE:VTMX) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.02 by 161.9 percent. This is a 19.57 percent increase over earnings of $0.05 per share from the
2025-10-24 05:10
Companies Reporting Before The Bell • Nokia (NYSE:NOK) is estimated to report q...
2025-10-23 16:32
Vesta Real Estate (NYSE:VTMX) will release its quarterly earnings report on Thu...
2025-10-23 04:02
Corporación Inmobiliaria Vesta, S.A.B. de C.V. ("Vesta") (NYSE:VTMX, BMV:VESTA), a fully-integrated, internally managed real estate company that owns, manages, develops and leases industrial properties in Mexico, today
2025-09-25 20:13
今日重点评级关注:Benchmark:维持Unicycive Therapeutics"投机性买入"评级,目标价从3美元升至21美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从17美元升至25美元
2025-09-16 09:48